193 related articles for article (PubMed ID: 6539435)
1. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.
McGeer PL; McGeer EG; Suzuki J; Dolman CE; Nagai T
Neurology; 1984 Jun; 34(6):741-5. PubMed ID: 6539435
[TBL] [Abstract][Full Text] [Related]
2. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
3. A post-mortem study of the cholinergic and GABA systems in senile dementia.
Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
[TBL] [Abstract][Full Text] [Related]
4. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
[TBL] [Abstract][Full Text] [Related]
5. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
[TBL] [Abstract][Full Text] [Related]
7. The nucleus basalis in Huntington's disease.
Clark AW; Parhad IM; Folstein SE; Whitehouse PJ; Hedreen JC; Price DL; Chase GA
Neurology; 1983 Oct; 33(10):1262-7. PubMed ID: 6225032
[TBL] [Abstract][Full Text] [Related]
8. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
9. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
Whitehouse PJ; Price DL; Struble RG; Clark AW; Coyle JT; Delon MR
Science; 1982 Mar; 215(4537):1237-9. PubMed ID: 7058341
[TBL] [Abstract][Full Text] [Related]
11. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
Candy JM; Perry RH; Perry EK; Irving D; Blessed G; Fairbairn AF; Tomlinson BE
J Neurol Sci; 1983 May; 59(2):277-89. PubMed ID: 6854353
[TBL] [Abstract][Full Text] [Related]
12. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
Lippa CF; Smith TW; Perry E
J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
[TBL] [Abstract][Full Text] [Related]
13. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock GK; Esiri MM; Bowen DM; Hughes AO
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
Wilcock GK; Esiri MM; Bowen DM; Smith CC
J Neurol Sci; 1982 Dec; 57(2-3):407-17. PubMed ID: 7161627
[TBL] [Abstract][Full Text] [Related]
15. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004
[TBL] [Abstract][Full Text] [Related]
16. Neocortical cholinergic neurons in elderly people.
White P; Hiley CR; Goodhardt MJ; Carrasco LH; Keet JP; Williams IE; Bowen DM
Lancet; 1977 Mar; 1(8013):668-71. PubMed ID: 66473
[TBL] [Abstract][Full Text] [Related]
17. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.
Bowen DM; Benton JS; Spillane JA; Smith CC; Allen SJ
J Neurol Sci; 1982 Dec; 57(2-3):191-202. PubMed ID: 7161618
[TBL] [Abstract][Full Text] [Related]
18. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
19. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Davies P; Terry RD
Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
[TBL] [Abstract][Full Text] [Related]
20. Biochemical changes in the cholinergic system of the ageing brain and in senile dementia.
Bowen DM; Davison AN
Psychol Med; 1980 May; 10(2):315-9. PubMed ID: 6104344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
